Alprostadil (Caverject/MUSE) Cost in Alabama 2026

What Does Alprostadil Actually Cost in Alabama Right Now?

Brand alprostadil carries a retail list price of approximately $600 per month at Alabama pharmacies in 2026, whether dispensed as Caverject intracavernosal injection or MUSE urethral suppository. That price covers a single on-demand supply unit, not a 30-day daily regimen. Because alprostadil is used only when needed, monthly spend depends entirely on how often a patient uses it.

Alprostadil (prostaglandin E1) works by relaxing smooth muscle and dilating cavernosal arteries, producing an erection within 5 to 20 minutes of administration 1. The key Linet et al. trial published in the New England Journal of Medicine (N=296, 1996) found that alprostadil intracavernosal injection produced a successful sexual response in 94% of injection attempts versus 11% with placebo 1. That response rate explains why the drug remains a standard second-line therapy for erectile dysfunction despite its cost 2.

Alabama has 67 counties served by independent pharmacies, chain pharmacies, and hospital outpatient pharmacies. Cash prices vary slightly by location, but statewide pharmacy surveys for 2026 consistently place the average at $600 per month for a standard supply of either Caverject or MUSE 3. Patients in rural counties (roughly 40 of Alabama's 67 counties are classified rural by the USDA) may face longer drive times to pharmacies that stock alprostadil, which makes mail-order or telehealth-connected pharmacy fulfillment particularly practical 4.

The generic alprostadil injection (alprostadil sterile powder for reconstitution) carries essentially the same cash-pay price tier as Caverject at most Alabama retail locations, because the market remains limited. Do not assume generic means cheap here.

Does Alabama Medicaid Cover Alprostadil?

Alabama Medicaid does not cover alprostadil for erectile dysfunction in 2026. Erectile dysfunction is classified as a lifestyle condition under Alabama Medicaid's benefit exclusions, consistent with how most state Medicaid programs treat ED pharmacotherapy 5.

The Alabama Medicaid Agency's pharmacy benefit explicitly excludes drugs prescribed solely for erectile dysfunction, impotence, or sexual performance. This mirrors the federal Medicaid statute, which permits but does not require states to cover such agents 6. Alabama has elected not to cover them. Patients enrolled in Alabama Medicaid who need alprostadil must pay out of pocket or access compounded alternatives.

One important exception: if a prescriber documents alprostadil as medically necessary for a non-ED indication, such as peripheral vascular disease or Raynaud's phenomenon, coverage review may apply 7. That requires a specific ICD-10 code, a letter of medical necessity, and prior authorization. ED-specific claims will be denied.

Is Compounded Alprostadil Legal in Alabama?

Compounded alprostadil is legal in Alabama when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber 8. Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding and allows licensed pharmacists to prepare non-commercially available or customized formulations for individual patients 8.

Several Alabama-licensed 503A pharmacies prepare alprostadil intracavernosal injection in concentrations such as 10 mcg/mL, 20 mcg/mL, or 40 mcg/mL, sometimes combined with papaverine or phentolamine (so-called bi-mix or tri-mix) 9. The Alabama State Board of Pharmacy (ALBOP) regulates these operations and requires compliance with USP 797 sterile compounding standards 10. A prescription written by a physician, PA, or NP licensed in Alabama is required before any 503A pharmacy can dispense.

Compounded alprostadil can cost significantly less than the $600 brand list price, sometimes approaching a fraction of that cost per vial, depending on the pharmacy and formulation. That price gap is the primary clinical reason practitioners in Alabama often prefer 503A compounded products for cost-sensitive patients 11.

503B outsourcing facilities may also supply alprostadil, but they serve clinics and hospitals rather than individual patients. If a urology clinic or men's health clinic in Alabama draws alprostadil from a 503B facility, the drug may be administered in-office at a different price point than retail 12.

How Alabama Private Insurance and Medicare Handle Alprostadil

Private insurance coverage in Alabama varies widely by plan. Most commercial plans classify alprostadil under a specialty tier, and many apply annual caps or quantity limits 13. A standard prior authorization requires documentation of at least one oral PDE5 inhibitor failure (or contraindication) before alprostadil is approved 14.

Medicare Part D excludes drugs used for erectile dysfunction by statute under 42 U.S.C. 1395w-102(e)(2), which means no Medicare Part D plan may cover alprostadil for ED regardless of which plan a patient selects 15. Patients enrolled in Medicare Advantage (Part C) plans should check their supplemental drug benefit, but coverage for ED remains prohibited under federal law.

The American Urological Association 2018 guideline on erectile dysfunction states: "Vasoactive pharmacotherapy (intracavernosal injection, intraurethral suppository) should be offered to patients who are not candidates for or who have not responded to PDE5 inhibitors" 16. That guideline language is what prescribers cite when building a prior authorization case with commercial insurers.

Blue Cross and Blue Shield of Alabama, the state's largest insurer, lists alprostadil injection under a specialty tier with a quantity limit of 6 doses per 30 days and requires PDE5 inhibitor step therapy unless contraindicated. United Healthcare and Aetna plans sold in Alabama apply similar prior authorization criteria 13.

Telehealth Prescribing of Alprostadil in Alabama

Telehealth prescribing of alprostadil is legal in Alabama in 2026. Alabama lifted its pre-pandemic telemedicine restrictions and now permits prescribing of Schedule-exempt medications, including alprostadil, after a valid patient-provider relationship is established via synchronous video 17.

Alabama's telemedicine statute (Code of Alabama, Section 34-24-75.1) does not require an in-person visit before prescribing non-controlled medications. Alprostadil is not a controlled substance. A licensed Alabama physician, NP, or PA may conduct an initial telehealth evaluation covering medical history, cardiovascular risk, and prior ED treatment, then send a prescription electronically to a retail or compounding pharmacy in Alabama 17.

One practical requirement: injection training. The FDA label for Caverject specifies that patients must receive hands-on injection technique instruction from a healthcare provider before self-injecting 3. Most telehealth platforms satisfy this with a brief video demonstration plus a follow-up in-person visit to a local urology office or urgent care for the first supervised injection. Some Alabama-licensed telehealth men's health clinics partner with local pharmacies that offer in-store injection training at no separate fee 18.

Discount Programs and Savings Cards for Alprostadil in Alabama

Several discount mechanisms exist for Alabama patients paying cash for alprostadil.

Pfizer Patient Assistance Program. Pfizer offers a patient assistance program for Caverject through its PfizerRxPathways portal. Income-eligible patients (generally household income at or below 400% of the federal poverty level) may qualify for free or reduced-cost Caverject 19. Applications require proof of income, a prescriber signature, and confirmation of insurance status.

GoodRx and Similar Discount Cards. GoodRx, RxSaver, and NeedyMeds discount cards can reduce the retail price of brand or generic alprostadil at participating Alabama pharmacies, though savings on specialty products like alprostadil tend to be more modest than on common generics. The cash price after applying a GoodRx coupon at large chain pharmacies in Alabama (CVS, Walgreens, Walmart) has ranged from roughly $480 to $590 for a standard Caverject supply in 2026 20. Always check the coupon price at your specific zip code, because it varies by pharmacy contract.

Manufacturer Copay Cards. Pfizer's copay card for Caverject is available to commercially insured patients only. It does not apply to Medicare, Medicaid, or uninsured patients. Alabama patients with employer-sponsored insurance who meet the eligibility criteria can apply the card at the pharmacy counter to reduce out-of-pocket cost 19.

Compounding as a Cost Strategy. For patients who are uninsured, underinsured, or on Medicare, a prescription for compounded alprostadil from a licensed Alabama 503A pharmacy is the most direct path to a lower price. A physician, PA, or NP must specify the compounded formulation (concentration, volume, preservative-free or not) rather than simply writing "alprostadil" and letting the pharmacy substitute 8.

Clinical Dosing and Safety Context

Alprostadil intracavernosal injection is dosed between 1.25 mcg and 60 mcg, titrated in a clinical setting to the lowest effective dose that produces an erection lasting no more than 60 minutes 21. The FDA label for Caverject instructs prescribers to begin at 2.5 mcg for neurogenic erectile dysfunction and 5 mcg for vasculogenic or psychogenic causes, with dose increments at separate clinic visits 3.

MUSE (Medicated Urethral System for Erection) is the intraurethral pellet formulation approved in 1996, dosed at 125 mcg, 250 mcg, 500 mcg, or 1000 mcg per pellet. Response rates in published trials are lower than for intracavernosal injection: roughly 65% of men report sufficient erection for intercourse in controlled settings versus 80 to 90% with injection 22. Patients who prefer to avoid injection often start with MUSE and escalate to injection if needed.

Priapism (erection lasting more than 4 hours) occurs in approximately 1% to 4% of alprostadil users and requires emergency treatment 23. Alabama patients should be counseled to go to an emergency department if erection persists beyond 4 hours; delayed treatment risks permanent fibrosis and loss of erectile function. Penile pain at the injection site affects up to 37% of users and is the most common adverse effect leading to discontinuation 1.

The HealthRX Alabama Alprostadil Cost Decision Framework below summarizes the four access pathways by insurance status, guiding patients and prescribers to the most appropriate route before the first prescription is written.

| Patient Situation | Recommended Access Pathway | Estimated Monthly Cost (2026) | |---|---|---| | Commercial insurance, no step-therapy yet | Prior auth with PDE5 failure documentation | Copay per plan (often $30-$100) | | Medicare Part D, no supplemental | 503A compounded alprostadil | Varies by pharmacy | | Alabama Medicaid | 503A compounded alprostadil or non-ED ICD-10 review | Varies by pharmacy | | Uninsured, income-eligible | Pfizer PfizerRxPathways or 503A compounding | $0 (assistance) or reduced |

What to Expect at an Alabama Pharmacy

Alprostadil is not stocked at every Alabama pharmacy. Independent pharmacies and hospital-adjacent pharmacies in Birmingham, Huntsville, Mobile, and Montgomery are most likely to carry Caverject or MUSE on the shelf 24. Smaller pharmacies in rural counties may require 24 to 72 hours to order the product.

Call ahead. Confirm that the pharmacy stocks the specific product (Caverject Impulse 10 mcg, Caverject 20 mcg dual-chamber, or MUSE 500 mcg, for example) and ask for the exact cash price before driving. If the retail price is prohibitive, ask the pharmacist whether the prescriber can route the prescription to a 503A compounding partner 8.

Storage matters clinically. Caverject Impulse dual-chamber syringes store at room temperature below 25°C until the expiration date; reconstituted solution must be used within 24 hours and refrigerated 3. Compounded alprostadil vials typically require refrigeration at 2°C to 8°C and carry shorter beyond-use dates governed by USP 797, often 14 to 30 days 10. Patients receiving compounded products by mail should confirm cold-chain shipping.

Cardiovascular Safety and Prescribing Prerequisites in Alabama

Before any alprostadil prescription, a prescriber must assess cardiovascular fitness for sexual activity. The Princeton Consensus (Third Princeton Consensus Conference, 2012) stratified men into low, intermediate, and high cardiovascular risk categories and recommended that only low-risk patients (stable, controlled hypertension; asymptomatic with <3 risk factors) proceed without further cardiac evaluation 25. Intermediate-risk patients require stress testing before ED pharmacotherapy is initiated.

Alprostadil is contraindicated in men with conditions predisposing them to priapism (sickle cell disease, multiple myeloma, leukemia) and in those with penile anatomical deformities such as Peyronie's disease that would preclude safe injection 3. Unlike PDE5 inhibitors, alprostadil does not interact with nitrates, so it may be an option for men on nitrate therapy who cannot use sildenafil or tadalafil 26.

The combination of alprostadil with oral PDE5 inhibitors (sildenafil, tadalafil, vardenafil) carries a risk of hypotension and prolonged erection. This combination is not FDA-approved and requires explicit shared decision-making 27.